US · Healthcare

BioMark Diagnostics Inc (BMKDF)

Diagnostics & Research

BioMark Diagnostics Inc (BMKDF) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BMKDF

P/E ratio

18.00

BioMark Diagnostics Inc (BMKDF) — FAQ

What is BMKDF's P/E ratio?

The price-to-earnings (P/E) ratio for BioMark Diagnostics Inc (BMKDF) is 18.00 (data as of 2026-05-23).

Does BioMark Diagnostics Inc pay a dividend?

Dividend yield is not available in the current snapshot for BioMark Diagnostics Inc (BMKDF). Check the MyAverix Finance app for the latest dividend data.

What sector is BioMark Diagnostics Inc in?

BioMark Diagnostics Inc (BMKDF) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is BMKDF listed on?

BMKDF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)